Cargando…

Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer

This study investigates plan quality generated by an MR-Linac (MRL) treatment planning system (TPS) for 5-fraction stereotactic body radiation therapy (SBRT) of primary pancreatic cancer (PCa). In addition, an isotoxic dose escalation was investigated with the MRL TPS based on stereotactic MR-guided...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hawranko, Robert, Sohn, James J., Neiderer, Keith, Bump, Ed, Harris, Timothy, Fields, Emma C., Weiss, Elisabeth, Song, William Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104241/ https://www.ncbi.nlm.nih.gov/pubmed/35566712 http://dx.doi.org/10.3390/jcm11092584

Ejemplares similares

Direct tumor visual feedback during free breathing in 0.35T MRgRT
por: Kim, Taeho, et al.
Publicado: (2020)

Deep learning based automatic segmentation of organs-at-risk for 0.35 T MRgRT of lung tumors
por: Ribeiro, Marvin F., et al.
Publicado: (2023)

MOSFET dosimeter characterization in MR‐guided radiation therapy (MRgRT) Linac
por: Yadav, Poonam, et al.
Publicado: (2019)

Characterization of mechanical and radiation isocenter on an MR‐guided radiotherapy (MRgRT) Linac
por: Bassiri, Nema, et al.
Publicado: (2023)

Emergence of MR-Linac in Radiation Oncology: Successes and Challenges of Riding on the MRgRT Bandwagon
por: Das, Indra J., et al.
Publicado: (2022)

System‐dependent image distortion related to gantry positions of a 0.35 T MRgRT: Characterization and the corresponding correction
por: Marasini, Shanti, et al.
Publicado: (2022)

Characterization and longitudinal assessment of daily quality assurance for an MR‐guided radiotherapy (MRgRT) linac
por: Mittauer, Kathryn E., et al.
Publicado: (2019)

Evaluating motion of pancreatic tumors and anatomical surrogates using cine MRI in 0.35T MRgRT under free breathing conditions
por: Lewis, Benjamin, et al.
Publicado: (2023)

Characterization of radiotherapy component impact on MR imaging quality for an MRgRT system
por: Lewis, Benjamin C., et al.
Publicado: (2020)

Assessment of a novel commercial large field of view phantom for comprehensive MR imaging quality assurance of a 0.35T MRgRT system
por: Lewis, Benjamin C., et al.
Publicado: (2022)

Development and evaluation of a GEANT4‐based Monte Carlo Model of a 0.35 T MR‐guided radiation therapy (MRgRT) linear accelerator
por: Khan, Ahtesham Ullah, et al.
Publicado: (2021)

The quantification and potential impact of dark current on treatments with an MR‐guided radiotherapy (MRgRT) system
por: Shepard, Andrew J., et al.
Publicado: (2020)

An investigation of using log‐file analysis for automated patient‐specific quality assurance in MRgRT
por: Lim, Seng Boh, et al.
Publicado: (2021)

Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach
por: Boldrini, Luca, et al.
Publicado: (2018)

Why we should care about gas pockets in online adaptive MRgRT: a dosimetric evaluation
por: Nardini, Matteo, et al.
Publicado: (2023)

Evaluation of T2-Weighted MRI for Visualization and Sparing of Urethra with MR-Guided Radiation Therapy (MRgRT) On-Board MRI
por: Pham, Jonathan, et al.
Publicado: (2021)

Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning
por: Kim, Jung-in, et al.
Publicado: (2019)

Basics and Frontiers on Pancreatic Cancer for Radiation Oncology: Target Delineation, SBRT, SIB Technique, MRgRT, Particle Therapy, Immunotherapy and Clinical Guidelines
por: Cellini, Francesco, et al.
Publicado: (2020)

A standardized framework to evaluate the quality of studies using TDABC in healthcare: the TDABC in Healthcare Consortium Consensus Statement
por: Etges, Ana Paula Beck da Silva, et al.
Publicado: (2020)

Treating locally advanced lung cancer with a 1.5 T MR-Linac – Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy
por: Bainbridge, Hannah E., et al.
Publicado: (2017)

Isotoxic dose escalated radiotherapy for glioblastoma based on diffusion-weighted MRI and tumor control probability—an in-silico study
por: Pang, Yaru, et al.
Publicado: (2023)

Improved effectiveness of stereotactic radiosurgery in large brain metastases by individualized isotoxic dose prescription: an in silico study
por: Zindler, Jaap D., et al.
Publicado: (2018)

Technical design and concept of a 0.35 T MR-Linac
por: Klüter, Sebastian
Publicado: (2019)

Dose Escalation for Pancreas SBRT: Potential and Limitations of using Daily Online Adaptive Radiation Therapy and an Iterative Isotoxicity Automated Planning Approach
por: Rhee, Dong Joo, et al.
Publicado: (2023)

Analysis of data to Advance Personalised Therapy with MR-Linac (ADAPT-MRL)
por: de Leon, Jeremiah, et al.
Publicado: (2021)

Online Magnetic Resonance-Guided Radiotherapy (oMRgRT) for Gynecological Cancers
por: Portelance, Lorraine, et al.
Publicado: (2021)

Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinoma
por: Bouchart, Christelle, et al.
Publicado: (2021)

Intrafraction Prostate Motion Management During Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy
por: Panizza, Denis, et al.
Publicado: (2022)

Commissioning a secondary dose calculation software for a 0.35 T MR‐linac
por: Price, Alex T., et al.
Publicado: (2022)

Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study
por: Klaar, Rabea, et al.
Publicado: (2023)

From centralized DRG costing to decentralized TDABC-assessing the feasibility of hospital cost accounting for decision-making in Denmark
por: Malmmose, Margit, et al.
Publicado: (2021)

Dosimetric evaluation of respiratory gating on a 0.35‐T magnetic resonance–guided radiotherapy linac
por: Charters, John A., et al.
Publicado: (2022)

Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation
por: Manderlier, Martin, et al.
Publicado: (2022)

A Standardized Framework for Evaluating Surgical Enhanced Recovery Pathways: A Recommendations Statement from the TDABC in Health-care Consortium
por: Etges, Ana Paula B.S., et al.
Publicado: (2021)

OP 001-035
Publicado: (2005)

MRL and SuperFine+MRL: new supertree methods
por: Nguyen, Nam, et al.
Publicado: (2012)

IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer
por: Landau, David B., et al.
Publicado: (2016)

Evaluation of diffusion‐weighted MRI and geometric distortion on a 0.35T MR‐LINAC at multiple gantry angles
por: Lewis, Benjamin, et al.
Publicado: (2021)

Clinical experience of MRI(4D) QUASAR motion phantom for latency measurements in 0.35T MR‐LINAC
por: Kim, Taeho, et al.
Publicado: (2020)

Immune activation and MRgFUS
por: Ferrara, Katherine, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tu5btvf1aah2u30k7j3e883n6a